-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Purpose: Since obesity affects the immune response of cells to infection, our purpose is to investigate whether high body mass index (BMI) and high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels are related to the risk of multiple sclerosis (MS)
.
We also aim to explore the aspects of BMI, Epstein-Barr virus (EBV) infection (high EBNA-1 antibody levels and history of infectious mononucleosis [IM], respectively) at the age of 20, and human leukocyte antigen (HLA)-DRB1* 15:01 Potential relationship between alleles
Methods: A Swedish population-based case-control study (5460 cases and 7275 cases of control) was used to calculate the OR value (95% CIs) by logistic regression to evaluate overweight/obesity, IM history, EBNA-1 levels and HLA-DRB1 at the age of 20 *15:01 The relationship between MS risk
.
The potential interaction is evaluated on an additive scale
Results: Compared with normal weight, there is a significant correlation between overweight/obesity and high (>50th percentile) EBNA-1 antibody levels (the ratio caused by the interaction is 0.
2, 95% CI 0.
1-0.
4)
.
The higher the EBNA-1 antibody level, the stronger the interaction
Table 1 The confidence interval for multiple sclerosis in subjects with different combinations of body mass index and EBNA-1 antibody levels at the age of 20 is 95%
Table 1 The confidence interval for multiple sclerosis in subjects with different combinations of body mass index and EBNA-1 antibody levels at the age of 20 is 95%Table 2 The 95% CI of OR for subjects with different combinations of HLA-DRB1*15:01 status, 20-year-old BMI and IM medical history
Table 2 The 95% CI of OR for subjects with different combinations of HLA-DRB1*15:01 status, 20-year-old BMI and IM medical historyFigure HLA-DRB1*15:01, overweight/obesity (>25 kg/m 2 ), IM medical history and EBNA-1 status in different combinations of subjects compared with unexposed DRB1*15:01 negative subjects , The possibility of multiple sclerosis
Figure HLA-DRB1*15:01, overweight/obesity (>25 kg/m 2 ), IM medical history and EBNA-1 status in different combinations of subjects compared with unexposed DRB1*15:01 negative subjects , The possibility of multiple sclerosis 2Conclusion: In terms of MS risk, the two aspects of overweight/obesity in young adults and EBV infection have a synergistic effect, especially in people who are genetically susceptible to the disease
.
Obesity can not only induce chronic immune-mediated inflammation, but also affect the cellular immune response to infection
In terms of MS risk, the two aspects of overweight/obesity in young adults and EBV infection have a synergistic effect, especially in people who are genetically susceptible to the disease
Hedström AK, Brenner N, Butt J,et al, Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.
Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.
Leave a message here